Artelo Biosciences, Inc. Common Stock ARTL
Analyst Ratings
- Consensus
- Hold — 0 Buy · 1 Hold · 0 Sell (1 analysts)
- Avg. Price Target
- —
Key Stats
- Today's Range
- $3.90 – $15.73
- 50-Day Range
- $3.45 – $15.73
- 52-Week Range
- $3.45 – $270.00
- Volume
- 25.13 million shs
- Average Volume
- 945K shs
- Market Cap
- $2.27 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.27%
- Days to Cover
- 1.14
About Artelo Biosciences, Inc. Common Stock
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
Related Stocks
Compare head-to-head: ARTL vs LLY·ARTL vs JNJ·ARTL vs ABBV·ARTL vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.